Signs that the Federal Trade Commission (FTC) in the US may be softening its stance on pharma deals seem to have been misread, as the regulator has now sued to block Sanofi’s planned takeover of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results